Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 174   

Articles published

GSK 1,414.57 +1.57 (0.11%)
price chart
GlaxoSmithKline PLC
GlaxoSmithKline PLC incorporated in United Kingdom. The Company creates, discoveres, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products...more.
GlaxoSmithKline plc Is Still A Better Pick Than AstraZeneca plc
AstraZeneca It has been a terrible year for GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and more bad news could be around the corner.
Related articles »  
5 Things You May Not Know About Pay At GlaxoSmithKline plc
GlaxoSmithKline Executive pay continues to rankle many shareholders. So I'm reading the remuneration reports of leading FTSE 100 companies to help you decide whether your investments are being run by herd of 'fat cats'.
Why I Bought GlaxoSmithKline plc
Investing is akin to predicting the future, but while I can't tell you exactly how the world will look in 10 years' time, I can tell you what will be the same.
GlaxoSmithKline Pakistan Limited  Business Recorder
GlaxoSmithKline (GSK) Fined $488.8 Million For Bribery Network Over ...  The Inquisitr
Related articles »  
Why GlaxoSmithKline plc Has Further To Fall
Investors in pharmaceutical giant GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have taken a beating lately. At 1450p, the stock is 15% off its 52-week high of 1706p.
China's decision to impose a record fine on GlaxoSmithKline Plc...  Mynextfone
Glaxo's China Fine Signals No Immunity for Multinationals  Businessweek
Related articles »  
Why GlaxoSmithKline plc Should Lag The FTSE 100 This Year
Announced on 19 September, the Chinese court found that Glaxo's Chinese subsidiary had illegally ´┐Żoffered money or property to non-government personnel in order to obtain improper commercial gains, and been found guilty of bribing non-government ...
Analysts' Recent Ratings Updates for GlaxoSmithKline plc (GSK)  WKRB News
How Will GlaxoSmithKline (GSK) Stock React To Shareholder Skepticism?
Related articles »  
5 Stunning Reasons Why GlaxoSmithKline plc And AstraZeneca plc Could ...
While investors in AstraZeneca (LSE: AZN) have experienced a very strong 2014 thus far, with shares in the pharmaceutical major gaining 27%, it's been a very different story for their counterparts in GlaxoSmithKline (LSE: GSK). Indeed, the latter has ...
GlaxoSmithKline plc (GSK) Updates on Tafinlar Survival Rates from Phase III ...
GlaxoSmithKline plc (NYSE: GSK) announced updated results for Tafinlar (dabrafenib) from a planned analysis of the phase III BREAK-3 study in 250 patients with BRAF V600E mutant metastatic melanoma.
Melanoma Treatment Battle Between Roche And GSK Heats Up  Bidness ETC
Glaxo Phase III Tafinlar Study Shows Survival Rate Of 45% At Two Years  London South East
Related articles »  
GlaxoSmithKline plc's Hold Rating Reiterated at Jefferies Group (GSK)
Jefferies Group reaffirmed their hold rating on shares of GlaxoSmithKline plc (NYSE:GSK) in a report issued on Tuesday. GlaxoSmithKline plc (NYSE:GSK) traded down 0.69% during mid-day trading on Tuesday, hitting $45.97. The stock had a trading volume ...
The FTSE 100′s Hottest Growth Stocks: GlaxoSmithKline plc
But in my opinion, GlaxoSmithKline's terrific record of getting its drugs from lab bench to pharmacy counter makes it an excellent pick for those seeking decent growth prospects.
Related articles »